Changes in plasma concentrations of vitronectin in patients with diabetic nephropathy.

S. Morioka, Hirofumi Makino, Kenichi Shikata, Z. Ota

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To investigate the role of vitronectin in the progression of diabetic nephropathy, plasma concentrations of vitronectin were measured by enzyme-linked immunosorbent assay in patients with diabetes mellitus and compared with normal control subjects. In diabetic patients with normoalbuminuria and microalbuminuria, plasma concentrations of vitronectin were significantly higher than those of control subjects. Plasma concentrations of vitronectin in diabetic patients with chronic renal failure were significantly lower than those with normal renal function. There was a significant positive correlation between plasma concentration of vitronectin and blood platelet counts. In the early stage of diabetic nephropathy, vitronectin may be increased caused by synthesis from activated platelets. With progression of diabetic nephropathy, plasma vitronectin may be decreased because of accumulation in sclerotic glomeruli and arteriosclerotic lesions. In conclusion, the plasma concentration of vitronectin appears to be an important marker for the progression of diabetic nephropathy.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalActa Medica Okayama
Volume48
Issue number3
Publication statusPublished - Jun 1994

Fingerprint

Vitronectin
Diabetic Nephropathies
Plasmas
Platelets
Immunosorbents
Medical problems
Platelet Count
Chronic Kidney Failure
Assays
Diabetes Mellitus
Blood
Blood Platelets
Enzyme-Linked Immunosorbent Assay
Kidney

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Changes in plasma concentrations of vitronectin in patients with diabetic nephropathy. / Morioka, S.; Makino, Hirofumi; Shikata, Kenichi; Ota, Z.

In: Acta Medica Okayama, Vol. 48, No. 3, 06.1994, p. 137-142.

Research output: Contribution to journalArticle

@article{563ae952ca5045f8a06ba13560752956,
title = "Changes in plasma concentrations of vitronectin in patients with diabetic nephropathy.",
abstract = "To investigate the role of vitronectin in the progression of diabetic nephropathy, plasma concentrations of vitronectin were measured by enzyme-linked immunosorbent assay in patients with diabetes mellitus and compared with normal control subjects. In diabetic patients with normoalbuminuria and microalbuminuria, plasma concentrations of vitronectin were significantly higher than those of control subjects. Plasma concentrations of vitronectin in diabetic patients with chronic renal failure were significantly lower than those with normal renal function. There was a significant positive correlation between plasma concentration of vitronectin and blood platelet counts. In the early stage of diabetic nephropathy, vitronectin may be increased caused by synthesis from activated platelets. With progression of diabetic nephropathy, plasma vitronectin may be decreased because of accumulation in sclerotic glomeruli and arteriosclerotic lesions. In conclusion, the plasma concentration of vitronectin appears to be an important marker for the progression of diabetic nephropathy.",
author = "S. Morioka and Hirofumi Makino and Kenichi Shikata and Z. Ota",
year = "1994",
month = "6",
language = "English",
volume = "48",
pages = "137--142",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "3",

}

TY - JOUR

T1 - Changes in plasma concentrations of vitronectin in patients with diabetic nephropathy.

AU - Morioka, S.

AU - Makino, Hirofumi

AU - Shikata, Kenichi

AU - Ota, Z.

PY - 1994/6

Y1 - 1994/6

N2 - To investigate the role of vitronectin in the progression of diabetic nephropathy, plasma concentrations of vitronectin were measured by enzyme-linked immunosorbent assay in patients with diabetes mellitus and compared with normal control subjects. In diabetic patients with normoalbuminuria and microalbuminuria, plasma concentrations of vitronectin were significantly higher than those of control subjects. Plasma concentrations of vitronectin in diabetic patients with chronic renal failure were significantly lower than those with normal renal function. There was a significant positive correlation between plasma concentration of vitronectin and blood platelet counts. In the early stage of diabetic nephropathy, vitronectin may be increased caused by synthesis from activated platelets. With progression of diabetic nephropathy, plasma vitronectin may be decreased because of accumulation in sclerotic glomeruli and arteriosclerotic lesions. In conclusion, the plasma concentration of vitronectin appears to be an important marker for the progression of diabetic nephropathy.

AB - To investigate the role of vitronectin in the progression of diabetic nephropathy, plasma concentrations of vitronectin were measured by enzyme-linked immunosorbent assay in patients with diabetes mellitus and compared with normal control subjects. In diabetic patients with normoalbuminuria and microalbuminuria, plasma concentrations of vitronectin were significantly higher than those of control subjects. Plasma concentrations of vitronectin in diabetic patients with chronic renal failure were significantly lower than those with normal renal function. There was a significant positive correlation between plasma concentration of vitronectin and blood platelet counts. In the early stage of diabetic nephropathy, vitronectin may be increased caused by synthesis from activated platelets. With progression of diabetic nephropathy, plasma vitronectin may be decreased because of accumulation in sclerotic glomeruli and arteriosclerotic lesions. In conclusion, the plasma concentration of vitronectin appears to be an important marker for the progression of diabetic nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=0028452364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028452364&partnerID=8YFLogxK

M3 - Article

C2 - 7524268

AN - SCOPUS:0028452364

VL - 48

SP - 137

EP - 142

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 3

ER -